NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
05/30/2026
Back to search
Official data from USPTO
DEALBUMIN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
05/31/2026
Trademark type
Word
Nice classes
1, 5
Filing date
12/19/2019
Registration date
10/27/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/30/2026
Last transaction
05/31/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
10/10/2018
First use in commerce
04/29/2019
Drawing code
4
Owner type
03
Owner location
NEW TAIPEI CITY, TW
Examiner
CALLOWAY, CHRISTINA DENISE
Current location
Historical data usage
Holders and representatives
Holders
A. C. (pessoa física)
Representatives
Alan Taboada MOSER TABOADA
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Protein for industrial use; Protein in raw material form for scientific and medical research; Proteins for use in the manufacture of cell culture mediacryopreservation reagentexcipient; Albumin for industrial purposes; Albumin for use in the manufacture of cell culture mediacryopreservation reagentexcipient; Chemicals for use in industry and science; Chemical preparations for use in industry; chemical additives for use in the manufacture of pharmaceuticals; Cell culture media for laboratory use; Cell growth media for growing cells for scientific and research use; Excipients for use in the manufacture of pharmaceutical preparationsveterinary preparations; Biological preparation for use in cell cultures other than for medical or veterinary use; Biological preparations for use in industry and science; Diagnostic preparations for scientific or research use; Preservatives for use in the pharmaceutical industry; Adjuvantsother than for medical or veterinary purposes
Class 5
Diagnostic reagents for medicinal use; Diagnostic preparations for medical purposes; Albuminous preparations for medical purposes; Culture media for cultivating humananimal and microorganism cells; Diagnostic media for bacteriological cultures; Diagnostic agentspreparations and substances for medical purposes; Cell growth media for growing cells for medical or clinical use; Reagents and media for medical and veterinary diagnostic purposes; Adjuvants for medical purposes
Publications
History of USPTO decisions and trademark events.
19 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
05/30/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/30/2026
E815
TEAS SECTION 8 & 15 RECEIVED
03/09/2026
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/27/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
10/27/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/11/2020
PUBO
PUBLISHED FOR OPPOSITION
08/11/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/22/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/06/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/10/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/09/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/09/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/30/2020
GNRT
NON-FINAL ACTION E-MAILED
03/30/2020
CNRT
NON-FINAL ACTION WRITTEN
03/30/2020
DOCK
ASSIGNED TO EXAMINER
03/18/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/28/2019
NWAP
NEW APPLICATION ENTERED
12/23/2019
Continuous trademark protection
Get notified about every new filing that threatens DEALBUMIN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.